Board Meetings for MEDICAMEQ
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| MEDICAMEQ | Medicamen Biotech Limited | 27 May 2026 | Board Meeting Intimation | MEDICAMEN BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 27-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend. | |
| MEDICAMEQ | Medicamen Biotech Limited | 27 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend | |
| MEDICAMEQ | Medicamen Biotech Limited | 13 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 | |
| MEDICAMEQ | Medicamen Biotech Limited | 13 Feb 2026 | Board Meeting Intimation | MEDICAMEN BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 . | |
| MEDICAMEQ | Medicamen Biotech Limited | 14 Nov 2025 | Board Meeting Intimation | MEDICAMEN BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2025 . | |
| MEDICAMEQ | Medicamen Biotech Limited | 14 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 | |
| MEDICAMEQ | Medicamen Biotech Limited | 12 Aug 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 | |
| MEDICAMEQ | Medicamen Biotech Limited | 12 Aug 2025 | Board Meeting Intimation | MEDICAMEN BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 12-Aug-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2025 . | |
| MEDICAMEQ | Medicamen Biotech Limited | 30 May 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2025 and dividend | |
| MEDICAMEQ | Medicamen Biotech Limited | 30 May 2025 | Board Meeting Intimation | MEDICAMEN BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Dividend/Other business. | |
| MEDICAMEQ | Medicamen Biotech Limited | 26 Feb 2025 | Board Meeting Intimation | MEDICAMEN BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 26-Feb-2025 to consider Fund raising. | |
| MEDICAMEQ | Medicamen Biotech Limited | 26 Feb 2025 | Fund Raising | Pursuant to Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ), we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, February 26, 2025, inter alia, Consider and approve a proposal for raising of funds by way of issuance of one or more instruments including equity shares/ convertible securities either by way of Preferential Issue/ Rights Issue/ QIP/ or any other mode as may be considered or as may be deemed fit and/or other modalities including determination of price thereon. | |
| MEDICAMEQ | Medicamen Biotech Limited | 11 Feb 2025 | Financial Results | To consider and approve the financial results for the period ended December 31, 2024 | |
| MEDICAMEQ | Medicamen Biotech Limited | 11 Feb 2025 | Board Meeting Intimation | MEDICAMEN BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 11-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 . | |
| MEDICAMEQ | Medicamen Biotech Limited | 14 Nov 2024 | Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
Showing page 1 of 3 (33 total items)